AI / data analytics / healthtech / informatics

SLAS Europe 2023 will take place 22-26 May in Brussels, Belgium, where attendees will embrace the theme Science Set in Motion. DDW’s Multimedia Editor Megan Thomas explores what to expect from the event. Scientific tracks SLAS Europe 2023 will feature four tracks focused on life sciences and their global impact: Biology Unveiled, Frontiers in Technology, […]

An investigational deep learning model requiring one histopathologic slide accurately predicted the risk of distant recurrence in patients with endometrial cancer, according to findings presented at the AACR Annual Meeting 2023. Endometrial cancer is the most common type of uterine cancer. While patients with early-stage uterine cancer have an approximately 95% five-year survival rate, those […]

Sascha Fischer Business Development Manager for Automation at Genedata looks at three critical digitalisation components that enable end-to-end lab automation, improve the return on investment (ROI) on instrumentation investments and streamline time-to-market.  Heightened regulatory demands, increasingly competitive markets, more challenging emergency medical needs, and remote working (underscored during Covid) — are just a few of […]

Oliver Schon, PhD, is VP Research & Development at BiVictriX Therapeutics, a UK-based emerging drug discovery and development company generating a pioneering first-in-class next-generation ADC anti-cancer therapeutics which exhibit superior selectivity towards cancer. Dr Schon is applying his broad expertise from lead discovery to manufacture in order to progress differentiated, safe and developable bi-specific therapeutic […]

This paid-for advertorial by BC Platforms appeared in DDW Volume 24 – Issue 2, Spring 2023 BC Platforms’ Global Data Partner Network provides patient-level, longitudinal, and geographically diverse real-world data and real-world evidence for use as external control arms in randomised human clinical trials, which can accelerate medicinal product regulatory filings and market access. In […]

The Spring 2023 issue of Drug Discovery World Magazine is out now. Featuring a Therapeutic Spotlight on Neuroscience, the magazine is available to download free here and read for free on the DDW App. You can also request to receive a copy of the printed magazine here. Key features of the Spring issue include a market report on the US drug discovery […]

US-based start-up Atomic AI is using artificial intelligence (AI) to design more intelligent RNA-targeted and RNA-based medicines. Diana Spencer spoke to Raphael Townshend, PhD, Founder and CEO of Atomic AI, about the advantages of combining two such exciting technologies. Artificial Intelligence (AI) has been enthusiastically adopted by the drug discovery sector as a tool for […]

This is the latest episode of the free DDW podcast, “Data integrity and the value of the cloud”. It covers two articles written for the exclusive DDW & SLAS2022 supplement published in Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “The concept of data integrity” and “Remote working: when the cloud meets the lab”. […]

You’re in R&D, so you know the key to success is mastering your workflow. With so many different tasks to keep track of, it’s easy to feel overwhelmed and bogged down by manual data entry, paper-based processes, and transcription errors. You’ve heard of ELNs, but you may be unfamiliar with how they can help streamline […]

You’re in R&D, so you know the key to success is mastering your workflow. With so many different tasks to keep track of, it’s easy to feel overwhelmed and bogged down by manual data entry, paper-based processes, and transcription errors. You’ve heard of ELNs, but you may be unfamiliar with how they can help streamline […]

Iktos has raised €15.5m in a Series A funding round to expand its artificial intelligence-based drug discovery technologies and solutions. The round was co-led by new investors M Ventures and Debiopharm Innovation Fund with participation from Omnes Capital. The financing will enable the company to launch Iktos Robotics; a drug discovery platform which combines artificial […]

African researchers are now able to access Collaborative Drug Discovery’s CDD Vault resource for neglected disease drug discovery collaborations.  Collaborative Drug Discovery (CDD), a scientific informatics company that provides data management and analysis solutions, is offering free subscriptions to CDD Vault for select academic teams of scientists in Africa who are developing new drugs to combat neglected […]

By Lucy Radley, Head of EU Regulatory Development, ProPharma. A rare disease is defined as a condition which affects less than one in 2000 people. Although individually they are very rare, collectively they are common with one in 17 people (around 3.5 million) in the UK being affected by a rare disease at some point […]

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML) methods offer an alluring way to expedite the […]

Antiverse has successfully identified functional antibody clusters targeting two G-protein-coupled receptors (GPCRs), both displaying versatile binding profiles and nanomolar affinity.  The company has raised $3 million in funding, which will enable in-house development of the antibodies showing the highest affinity blocking function. The antibodies were identified using Antiverse’s proprietary computational antibody drug discovery platform, which […]

New kids on the block, Atomic AI, recently closed a $35 million series A financing. DDW’s Diana Spencer speaks to Raphael Townshend PhD, Founder and CEO of Atomic AI, about the company’s successes so far, plans for the future and the unique approach of combining RNA structural biology and AI models.  DS: Congratulations on closing a […]